---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-036851"
form_type: "8-K"
ticker: "BCLI"
cik: "0001137883"
company_name: "BRAINSTORM CELL THERAPEUTICS INC."
filed_at: "2025-04-21T23:59:59+00:00"
generated_at: "2026-05-23T10:00:52.236015+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Brainstorm Cell Therapeutics amends bylaws to reduce quorum to 1/3; sets 2025 annual meeting for June 25

## Summary
- Board approved reducing stockholder quorum from majority to one-third of outstanding shares.
- 2025 Annual Meeting to be held virtually on June 25, 2025 at 10:00 a.m. ET.
- Record date for voting is May 7, 2025; shareholder proposals due by same date.
- Director nominations under universal proxy rules must be received by May 1, 2025.

## SEC filing metadata
- accession: 0001104659-25-036851
- form_type: 8-K
- ticker: BCLI
- cik: 0001137883
- company_name: BRAINSTORM CELL THERAPEUTICS INC.
- filed_at: 2025-04-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.03, 5.08, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1137883/000110465925036851/0001104659-25-036851-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1137883/000110465925036851/tm2512729d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-036851
- JSON: https://secwatch.observer/filing/0001104659-25-036851.json
- Plain text: https://secwatch.observer/filing/0001104659-25-036851.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.